Portfolio yield
Data as at : 31/12/2025
| % |
|---|
| 0.2 |
Please note that the above fields are displayed for companies that have reported this data to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/09/2025
| Investment | % of total assets |
|---|---|
| Vera Therapeutics Inc Class A | 5.6 |
| Soleno Therapeutics Inc | 5.4 |
| KalVista Pharmaceuticals Inc | 4.0 |
| Avidity Biosciences Inc Ordinary Shares | 3.9 |
| Amgen Inc | 3.6 |
| Sv Bcof | 3.6 |
| Sv Fund Vi Investment | 3.2 |
| Autolus Therapeutics PLC ADR | 3.1 |
| Cytokinetics Inc | 2.9 |
| Scb Sholo211123b 22-May-2025 5.41% 23-Jun-2025 | -5.7 |
Geographic breakdown
Data as at : 31/12/2025
| Country | % of total assets |
|---|---|
| USA | 60.4 |
| UK | 11.9 |
| Cayman Islands | 5.8 |
| Netherlands | 5.1 |
| Denmark | 4.8 |
| Singapore | 1.9 |
| Germany | 1.4 |
| Ireland | 1.3 |
| Canada | 1.0 |
| France | 0.9 |
| Switzerland | 0.3 |
| Australia | 0.3 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 30/09/2025
| Industry | % of total assets |
|---|---|
| Healthcare | 97.6 |
| Preferred | 0.3 |
Asset breakdown
Data as at : 30/09/2025
| Asset | % of total assets |
|---|---|
| Stock | 98.8 |
| Other | 6.8 |
| Bond | -5.7 |
Detailed asset breakdown
Data as at : 30/09/2025
| Asset | % of total assets |
|---|---|
| North America - stock | 87.0 |
| Other | 6.8 |
| Other - stock | 4.4 |
| Asia (excl Japan) - stock | 2.7 |
| Europe - Large-cap stock | 1.6 |
| Europe - Mid-cap stock | 1.4 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.